Cero Therapeutics Holdings Inc (CERO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Operating Expenses | 16,198 | 7,675 | 2,905 | 332 | 0 |
| Operating Income | -16,198 | -7,675 | -2,905 | -332 | N/A |
| Other Income | 7,894 | 385 | 2,837 | 0 | 0 |
| Pre-tax Income | -8,304 | -7,290 | -69 | -332 | 0 |
| Income Tax | N/A | N/A | 599 | -17 | N/A |
| Net Income Continuous | -8,304 | -7,290 | -668 | -316 | N/A |
| Net Income | $-8,304 | $-7,290 | $-668 | $-316 | $N/A |
| EPS Basic Total Ops | -382.76 | -24,972.80 | -60.00 | -60.00 | N/A |
| EPS Basic Continuous Ops | -286.64 | -24,972.86 | -290.56 | -136.97 | N/A |
| EPS Diluted Total Ops | -382.76 | -24,972.80 | -60.00 | -60.00 | N/A |
| EPS Diluted Continuous Ops | -286.64 | -24,972.86 | -290.56 | -136.97 | N/A |
| EBITDA(a) | $-15,037 | $-6,558 | $-2,905 | $-332 | $N/A |